Merck
  • Eriocitrin, a dietary flavonoid suppressed cell proliferation, induced apoptosis through modulation of JAK2/STAT3 and JNK/p38 MAPKs signaling pathway in MCF-7 cells.

Eriocitrin, a dietary flavonoid suppressed cell proliferation, induced apoptosis through modulation of JAK2/STAT3 and JNK/p38 MAPKs signaling pathway in MCF-7 cells.

Journal of biochemical and molecular toxicology (2021-11-02)
Chengliang Yuan, Guoping Chen, Chengbao Jing, Mengxue Liu, Bo Liang, Guojin Gong, Mei Yu
RESUMEN

Eriocitrin, a lemons flavanone, exhibits several biological properties, antiproliferative, and proapoptotic effects. However, its molecular mechanical action is not entirely clarified. Oxidative stress causes abnormal stimulation of signal transducer and activator of transcription 3 (STAT3) and c-Jun NH2-terminal kinase (JNK), p38 mitogen-activated protein kinases (MAPKs) signaling has been strongly connected with the ruling of cell survival and apoptosis of cancer cells. Herein, we investigated an antiproliferative and proapoptotic effect that Eriocitrin modulates STAT3/MAPKs signaling activation in MCF-7 cells. We noticed that Eriocitrin strongly enhances reactive oxygen species (ROS) generation, alteration of mitochondrial outer membrane potential, and enhances apoptotic morphological changes. Furthermore, Eriocitrin suppressed STAT3 phosphorylation via inhibiting an upstream molecule of JAK2 and Src kinase activation, thereby blocking STAT3 nuclear translocation. Similarly, Eriocitrin causes oxidative stress-mediated JNK/p38 MAPK signaling activation. We confirmed that Eriocitrin induced ROS-mediated apoptosis inhibited by the antioxidant substance of N-acetylcysteine. Eriocitrin induced apoptosis via suppression of STAT3 signaling regulated proteins, activating proapoptotic factors Bax, caspase 7, 8, 9 and suppressing Bcl-2, Bcl-x expression in MCF-7 cells. Overall, these results evidenced that Eriocitrin can affect multiple signaling events associated with tumorigenesis. From this evidence, Eriocitrin, a novel chemotherapeutic agent, can be used to treat breast cancer.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Monoclonal Anti-Caspase 11 antibody produced in rat, clone 17D9, purified from hybridoma cell culture
Sigma-Aldrich
Monoclonal Anti-Cyclin D1 antibody produced in mouse, clone DCS-6, ascites fluid
Sigma-Aldrich
Anti-p38 MAP Kinase, Activated (Diphosphorylated p38) antibody, Mouse monoclonal, clone P38-TY, purified from hybridoma cell culture, buffered aqueous solution
Sigma-Aldrich
Anti-JNK antibody, Mouse monoclonal, clone 1C2, purified from hybridoma cell culture
Sigma-Aldrich
Anti-Phospho-STAT3 (Tyr705) antibody, Rabbit monoclonal, recombinant, expressed in HEK 293 cells, clone RM261, purified immunoglobulin
Sigma-Aldrich
Anti-phospho JNK (Thr183, Tyr185) Antibody, clone 3F7, ZooMAb® Rabbit Monoclonal, recombinant, expressed in HEK 293 cells
Sigma-Aldrich
Anti-Caspase 9 antibody,Mouse monoclonal, clone CAS9, purified from hybridoma cell culture
Sigma-Aldrich
Anti-JAK2 antibody, Mouse monoclonal, clone 10.1.5, purified from hybridoma cell culture